November 2023 – Page 18

Nov 03 2023

AI Could Help Detect Schizophrenia From People’s Speech

by Clinical Editor

No Comments

A recent study published in the Proceedings of the National Academy of Sciences (PNAS) shows the potential of using artificial intelligence (AI) language models to find speech signatures in patients...

Nov 03 2023

Uncategorized

Stars who were diagnosed with schizophrenia

by Clinical Editor

No Comments

Thankfully, that makes schizophrenia one of the rarer mental disorders affecting people today, but it is still a daily struggle for those who bear its weight. Even today the disorder...

Nov 02 2023

Uncategorized

CPD: 14-year-old diagnosed with schizophrenia, bipolar missing – WGN TV Chicago

by Clinical Editor

No Comments

CPD: 14-year-old diagnosed with schizophrenia, bipolar missing WGN TV Chicago

Nov 02 2023

Uncategorized

A Beautiful Mind Ending Explained – Screen Rant

by Clinical Editor

No Comments

A Beautiful Mind Ending Explained Screen Rant

Nov 02 2023

Uncategorized

Maine massacre: A THIRD of mass shooters have schizophrenia and 3MILLION Americans are living with reality-warping condition

by Clinical Editor

No Comments

Robert Card, an Army reservist and firearms instructor, was hospitalized in a mental health facility in June for an unspecified condition that experts, as well as his cousin, said showed...

Nov 02 2023

Uncategorized

Man with schizophrenia missing from Jonesboro

by Clinical Editor

No Comments

Clayton County police need help searching for a missing man diagnosed with schizophrenia last seen in the Jonesboro area. A Mattie’s Call, Georgia’s emergency missing alert for disabled or elderly...

Nov 02 2023

Uncategorized

Analyst Assessment On Reviva Pharmaceuticals’ Positive Schizophrenia Trial Data – Sees More Than 200% Upside In Stock

by Clinical Editor

No Comments

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine sig …

Nov 02 2023

Uncategorized

Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2023 Neuroscience Education Institute Congress

by Clinical Editor

No Comments

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people liv …

Nov 02 2023

Uncategorized